Schubert & CO Vertex Pharmaceuticals Inc Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$283.23 - $323.1 $2,265 - $2,584	-8 Reduced 19.51%	33 $10,000
Q4 2022 Jan 31, 2023	SELL	$285.76 - $321.48 $571 - $642	-2 Reduced 4.65%	41 $11,000
Q3 2022 Oct 21, 2022	BUY	$273.83 - $305.53 $3,012 - $3,360	11 Added 34.38%	43 $12,000
Q2 2022 Aug 01, 2022	BUY	$234.96 - $292.55 $4,464 - $5,558	19 Added 146.15%	32 $9,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $885 - $1,043	4 Added 44.44%	13 $3,000
Q4 2021 Jan 28, 2022	BUY	$177.01 - $223.45 $1,593 - $2,011	9 New	9 $2,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.